Given that overweight and obesity are established risk factors for CRC 10 and have also been shown to predict CRC survival in early onset CRC, 11 future research should clarify the extent to which GLP-1 RAs modulate these outcomes.
Researchers tracking full lipid panels should anticipate the most dramatic changes in the triglyceride and HDL fractions when studying higher retatrutide doses
Meanwhile, studies indicate the vast majoritymore than 70%of patients on standardized protocols experience side effects
Professor Hocking has received honoraria for lectures and/or manuscript writing from Lilly Australia, AstraZeneca, Amgen and Sanofi-Aventis, Nestl Health Sciences, iNova and Servier
Insurance coverage plays a big part in who can afford these newer treatments
Why GLP-1 Supportive Foods Are Worth Exploring GLP-1 stands for glucagon-like peptide-1